None listed
Conditions
Interventions
Procedure/Surgery : Key Information on the Intervention
This study is a prospective, single-arm observational feasibility study designed to evaluate the feasibility of total parietal peritonectomy (T
Sponsors
Chung-Ang Univerisity Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Primary epithelial ovarian, fallopian tube, or primary peritoneal cancer International Federation of Gynecology and Obstetrics stage stage III–IV disease Patients scheduled for cytoreductive surgery following neoadjuvant chemotherapy Patients requiring peritonectomy at the time of cytoreductive surgery Age = 18 years Eastern Cooperative Oncology Group performance status performance status 0–1 Patients who have voluntarily provided written informed consent
Exclusion criteria
Exclusion criteria: Patients who have undergone a secondary review surgery after neoadjuvant chemotherapy, or who did not undergo surgery Patients with concomitant active non-gynecologic malignancy Patients with toxicity of grade = 2 (CTCAE), excluding alopecia, following neoadjuvant chemotherapy Patients who refuse to provide informed consent Eastern Cooperative Oncology Group performance status performance status = 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Clavien–Dindo grade 3–5 postoperative complications | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-Free Survival (PFS);Recurrence rate at 6 and 12 months;Time from surgery to initiation of postoperative chemotherapy | — |
Countries
Korea, Republic of
Contacts
Public ContactEunju Lee
Chung-Ang Univerisity Hospital
Outcome results
None listed